Munafa Stock Market Course + Intraday & FNO calls 
MA NEWS why is Mastercard Incorporated price falling or rising
MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising
MA Mastercard Incorporated is falling or rising technical reasons
Technical analysis forecast of Mastercard Incorporated Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Mastercard Incorporated MA at this time. Stock is rising and might rise more.
It appears as if Mastercard Incorporated MA gave a large move recently.
Stock of Mastercard Incorporated (MA) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Mastercard Incorporated is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 540.4 as stoploss in an intra day sell trade for a target of 529.85. However, stock will show a bullish move above 540.4.
MA Mastercard Incorporated is falling or rising NEWS fundamental reasons
Pharma deal activity hits four-quarter low, but mega Sun Pharma acquisition drives value India's pharma and healthcare sector recorded 65 deals worth .9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a four-quarter low, Grant Thornton Bharat said. Sun Pharma's .8 billion Organon acquisition drove deal values, while - NEWS as on 2026-07-24 indiatimes.com
Domino effect: Gandhar Oil’s 20% upper circuit spurs rally in Savita Oil and Panama Petro. Here’s why Gandhar Oil Refinery hit the 20% upper circuit after reporting a 689% year-on-year jump in Q1 net profit, triggering a rally in peers Savita Oil and Panama Petrochem. Strong demand across PHPO, PIO and lubricants, along with expanding exports and higher-ma - NEWS as on 2026-07-23 indiatimes.com
Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain drag The healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence will likely see broad-based growth. Specialty products and biosimilars are expected to be key growth drivers. Hospital - NEWS as on 2026-07-22 indiatimes.com
Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatment Emcure Pharmaceuticals announced its brand Poviztra is now available for fatty liver treatment. This follows regulatory approval for treating metabolic dysfunction-associated steatohepatitis in adults. Poviztra contains innovator semaglutide manufactured i - NEWS as on 2026-07-20 indiatimes.com
India-UK FTA projected to boost Indian pharma exports by over 8% to 1 million in FY27: Pharmexcil Indian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agreement will eliminate tariffs on most products. This pact is expected to enhance the competitiveness of Indian generic - NEWS as on 2026-07-16 indiatimes.com
NCDEX to roll out Guar Korma futures from July 24 NCDEX will launch Guar Korma futures on July 24, giving exporters, processors and feed manufacturers a SEBI-regulated platform to hedge price risks. The contract completes the exchange-traded guar derivatives ecosystem, improves price discovery and is expe - NEWS as on 2026-07-15 indiatimes.com
OneSource Specialty Pharma partners with Formycon AG to manufacture biosimilars OneSource Specialty Pharma has announced a manufacturing partnership for biosimilars with Formycon AG. This collaboration will see OneSource providing integrated manufacturing capabilities for biosimilars. The partnership aims to expand access to high-qual - NEWS as on 2026-07-14 indiatimes.com
Nuvama initiates Buy call on Vedanta Aluminium shares, expects profitability to exceed historical average. Here's why Nuvama Institutional Equities and Motilal Oswal Financial Services have initiated coverage on Vedanta Aluminium with 'Buy' ratings and target prices of Rs 540, citing strong earnings growth, cost reduction initiatives, firm aluminium prices and robust cash - NEWS as on 2026-07-10 indiatimes.com
Dixon Tech, Syrma SGS, Amber shares surge up to 6%. What does customs duty relief mean? Shares of Dixon Technologies, Syrma SGS Technologies and Amber Enterprises rallied after the Centre expanded customs duty exemptions on electronics manufacturing machinery and components until 2029. The move is expected to reduce import costs, improve marg - NEWS as on 2026-07-09 indiatimes.com
More announcements and NEWS
MA Mastercard Incorporated current price & indicator signals
Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 24 Fri Jul 2026 | 539.66 | 529.69 to 540.00 | 0% | 1.06 times |
| 24 Fri Jul 2026 | 539.66 | 529.69 to 540.00 | 1.79% | 1.06 times |
| 23 Thu Jul 2026 | 530.16 | 523.61 to 534.56 | -0.34% | 0.5 times |
| 22 Wed Jul 2026 | 531.98 | 530.73 to 540.00 | -1.17% | 0.96 times |
| 21 Tue Jul 2026 | 538.30 | 536.85 to 544.34 | -1.68% | 1.22 times |
| 20 Mon Jul 2026 | 547.50 | 538.01 to 547.91 | 0.72% | 0.65 times |
| 17 Fri Jul 2026 | 543.60 | 540.23 to 551.72 | -1.44% | 1.33 times |
| 16 Thu Jul 2026 | 551.54 | 539.69 to 551.68 | 3.05% | 1.21 times |
| 15 Wed Jul 2026 | 535.21 | 529.08 to 541.23 | -0.55% | 1.3 times |
| 14 Tue Jul 2026 | 538.15 | 530.00 to 543.46 | 0.08% | 0.58 times |
| 13 Mon Jul 2026 | 537.70 | 530.71 to 539.93 | 2.11% | 1.19 times |
| 10 Fri Jul 2026 | 526.60 | 519.65 to 528.94 | 0.66% | 0.38 times |
Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
